Primary Care Clinics in Fossil, OR Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Asher Community Health Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 712 Jay St, Fossil, OR 97830 Phone: 541-763-2725 Fax: 833-601-2016 |
Asher Clinic Spray Field Office Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 712 Jay St, Fossil, OR 97830 Phone: 541-763-2725 Fax: 541-763-2850 |
Mitchell School - Field Office Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 712 Jay St, Fossil, OR 97830 Phone: 541-763-2725 Fax: 541-763-2850 |
Asher Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 712 Jay St., Fossil, OR 97830 Phone: 541-763-2725 Fax: 541-763-2850 |
News Archive
Sunshine Biopharma to enter Adva-27a Phase I clinical trial for Multi-Drug Resistant breast cancer
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it issued a letter to its shareholders advising that it had filed for patent protection worldwide and expects to enter Phase I clinical trials for its principal drug, Adva-27a, beginning with GMP manufacturing and animal tox studies.
Physical, psychosocial factors can significantly increase risk of low back pain
New research reveals the physical and psychosocial factors that significantly increase the risk of low back pain onset. In fact results published in Arthritis Care & Research, a journal of the American College of Rheumatology, show that being engaged in manual tasks involving awkward positions will increase the risk of low back pain by eight times. Those who are distracted during activities or fatigued also significantly increase their risk of acute low back pain.
Study shows significantly increased risk of heart attack in patients with Sj-gren's syndrome
A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed a significantly increased risk of heart attack in patients with Sj-gren's syndrome (SjS), particularly in the first year following diagnosis.
Quark Pharmaceuticals' siRNA drug candidates featured in two presentations at Glaucoma & Retinopathies 2010
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that two of its siRNA drug candidates were featured in the following two presentations at the Glaucoma & Retinopathies 2010 conference, which was held June 21-22, 2010 in London, UK.
› Verified 2 days ago